HRPK20110080B3 - Pripravak za lijeäśenje koštanih poremeä†aja i poremeä†aja zglobova - Google Patents

Pripravak za lijeäśenje koštanih poremeä†aja i poremeä†aja zglobova

Info

Publication number
HRPK20110080B3
HRPK20110080B3 HRP20110080AA HRP20110080A HRPK20110080B3 HR PK20110080 B3 HRPK20110080 B3 HR PK20110080B3 HR P20110080A A HRP20110080A A HR P20110080AA HR P20110080 A HRP20110080 A HR P20110080A HR PK20110080 B3 HRPK20110080 B3 HR PK20110080B3
Authority
HR
Croatia
Prior art keywords
treatment
extract
composition
preparation
resin extract
Prior art date
Application number
HRP20110080AA
Other languages
English (en)
Inventor
Zdravko MAUKO
Original Assignee
Zdravko MAUKO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zdravko MAUKO filed Critical Zdravko MAUKO
Priority to HRP20110080AA priority Critical patent/HRPK20110080B3/hr
Priority to PCT/HR2012/000002 priority patent/WO2012104663A1/en
Publication of HRP20110080A2 publication Critical patent/HRP20110080A2/hr
Publication of HRPK20110080B3 publication Critical patent/HRPK20110080B3/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Pripravak za liječenje koštanih poremećaja i poremećaja zglobova sastoji se od smjese suhog ekstrakta smole tamjana, suhog ekstrakta smole smirne i suhog ekstrakta laktoferina. Sinergijska učinkovitost sastavnica ovog pripravka znatno je bolja od zbroja učinkovitosti njegovih pojedinačnih sastavnica. Najbolji rezultati liječenja koštanih poremećaja kao što su artritis i artroza postižu se pripravkom u kojemu su ekstrakt smole tamjana, ekstrakt smole smirne i ekstrakt laktoferina zastupljeni u približnim težinskim omjerima 2:2:1. Pripravak se uzima oralno u formi tableta ili kapsula.
HRP20110080AA 2011-02-02 2011-02-02 Pripravak za lijeäśenje koštanih poremeä†aja i poremeä†aja zglobova HRPK20110080B3 (hr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HRP20110080AA HRPK20110080B3 (hr) 2011-02-02 2011-02-02 Pripravak za lijeäśenje koštanih poremeä†aja i poremeä†aja zglobova
PCT/HR2012/000002 WO2012104663A1 (en) 2011-02-02 2012-01-24 Composition for treatment of bone and joint disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HRP20110080AA HRPK20110080B3 (hr) 2011-02-02 2011-02-02 Pripravak za lijeäśenje koštanih poremeä†aja i poremeä†aja zglobova

Publications (2)

Publication Number Publication Date
HRP20110080A2 HRP20110080A2 (hr) 2012-08-31
HRPK20110080B3 true HRPK20110080B3 (hr) 2014-01-03

Family

ID=46602108

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20110080AA HRPK20110080B3 (hr) 2011-02-02 2011-02-02 Pripravak za lijeäśenje koštanih poremeä†aja i poremeä†aja zglobova

Country Status (2)

Country Link
HR (1) HRPK20110080B3 (hr)
WO (1) WO2012104663A1 (hr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104606585A (zh) * 2015-02-13 2015-05-13 焦振华 一种用于反应性骨关节炎的中药制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0248534A (ja) 1988-07-28 1990-02-19 Bio Serae Sa:Soc 抗菌組成物の配合方法及び配合された抗菌組成物
JP3184923B2 (ja) 1992-01-08 2001-07-09 ビオ セレ ラボラトワール エス ア 抗リウマチ剤
WO2002085921A2 (de) * 2001-03-01 2002-10-31 Johann Jauch Einfaches verfahren zur synthese von boswelliasäuren und derivaten davon
JPWO2007049757A1 (ja) 2005-10-27 2009-04-30 サンスター株式会社 ラクトフェリンを含んだリポソームを含有する破骨細胞増加抑制剤、経口組成物及び骨疾患の予防又は治療剤
CN100518763C (zh) * 2006-09-01 2009-07-29 胡庆华 治疗寒湿骨痹的中药
CN100502929C (zh) * 2007-02-06 2009-06-24 程宝良 养血滋阴逐痹丸

Also Published As

Publication number Publication date
WO2012104663A1 (en) 2012-08-09
HRP20110080A2 (hr) 2012-08-31

Similar Documents

Publication Publication Date Title
MX343687B (es) Compuestos sulfonamida tricíclica y métodos para su fabricación y uso.
MY196319A (en) Polycyclic TLR7/8 Antagonists and use Thereof in the Treatment of Immune Disorders
MX345535B (es) Compuestos tricíclicos parcialmente saturados y métodos para su fabricación y su uso.
EA201791702A1 (ru) Терапевтические средства на основе гликанов и связанные с ними способы
WO2012154679A8 (en) Tricyclic pyrazole sulfonamide compounds and methods of making and using same
CL2013002210A1 (es) Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano.
CO6680658A2 (es) Agonista de gpr 40
MX2014008705A (es) Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos.
MX2014008706A (es) Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos.
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
MX339201B (es) Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
CO6690805A2 (es) 6-amino-nicotinamidas sustituidas como modulares de kcnq2/3
SG10201806854XA (en) Compositions comprising 15-ohepa and methods of using the same
CR20130602A (es) Compuestos novedosos como inhibidores de diacilglicerol aciltransferasa
MX354411B (es) Composición mejorada de dulzura que comprende esteviósido y rebaudiósido a.
TN2014000046A1 (en) Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
CL2021003291A1 (es) Mezcla de extractos de plantas para su uso en la prevención y/o tratamiento de enfermedades inflamatorias crónicas del intestino.
MY171048A (en) Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
MX2015005734A (es) Metodos de tratamiento de enfermedades hepaticas.
PH12017500743A1 (en) Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
WO2013184879A3 (en) Pumpable fat compositions
HRPK20110080B3 (hr) Pripravak za lijeäśenje koštanih poremeä†aja i poremeä†aja zglobova

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AKOB Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent)
PKB1 Consensual patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190125

Year of fee payment: 9

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200128

Year of fee payment: 10

PK10 Patent expired after termination of 10 years for consensual patent

Effective date: 20210202